Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Rhythm Biosciences Ltd, an Australian medical diagnostics firm, has successfully retained its ISO 13485:2016 certification for the sixth year in a row, ensuring its ColoSTAT® Test-Kit meets international quality standards for safe medical devices. This certification is pivotal for the company’s regulatory compliance, operational readiness, and global commercialization efforts, reinforcing market confidence in its innovative blood test designed for the early detection of colorectal cancer.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.
